Clinical Trials Logo

CYP2D6 Polymorphism clinical trials

View clinical trials related to CYP2D6 Polymorphism.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04228315 Recruiting - Malaria Clinical Trials

Biomarkers of P. Vivax Relapse

Start date: November 19, 2019
Phase: N/A
Study type: Interventional

Plasmodium vivax malaria is difficult to manage because even after taking medicine that kills the infection in the blood, it can continue to hide quietly in the liver, later re-emerging into the blood and causing another episode of malaria illness (relapse). This clinical trial aims to enroll patient with P. vivax infections and try to detect signals in blood, urine and/or saliva coming from the silent liver stages to help identify who could benefit from treatment with primaquine. It also will explore if certain factors of patients negatively impact primaquine efficacy.